These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17372342)

  • 1. Histopathological findings after retinal endovascular lysis in central retinal vein occlusion.
    Feltgen N; Agostini H; Auw-Haedrich C; Hansen LL
    Br J Ophthalmol; 2007 Apr; 91(4):558-9. PubMed ID: 17372342
    [No Abstract]   [Full Text] [Related]  

  • 2. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study.
    Feltgen N; Junker B; Agostini H; Hansen LL
    Ophthalmology; 2007 Apr; 114(4):716-23. PubMed ID: 17141322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.
    Hattenbach LO; Friedrich Arndt C; Lerche R; Scharrer I; Baatz H; Margaron F; Richard G; Behrens-Baumann W; Ohrloff C
    Retina; 2009; 29(7):932-40. PubMed ID: 19584651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombolytic therapy with recombinant tissue-type plasminogen activator in patients with branch or central vein occlusion of the retina].
    Kreutzer A; Brunner R; Schäfer HJ; Sickel W; Auel H; Hossmann V
    Fortschr Ophthalmol; 1988; 85(5):511-3. PubMed ID: 3147230
    [No Abstract]   [Full Text] [Related]  

  • 5. Surgical treatment of central retinal vein occlusion.
    Berker N; Batman C
    Acta Ophthalmol; 2008 May; 86(3):245-52. PubMed ID: 18494725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal vein occlusion and low-dose fibrinolytic therapy.
    Chhablani J; Babu A; Caraza M
    Retina; 2010 May; 30(5):840; author reply 840-2. PubMed ID: 20453808
    [No Abstract]   [Full Text] [Related]  

  • 7. Retinal surgery for treatment of central retinal vein occlusion.
    Weiss JN
    Ophthalmic Surg Lasers; 2000; 31(2):162-5. PubMed ID: 10743932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of central retinal vein occlusion forming the epiretinal membrane].
    Ohkita T; Ikeda T; Matsumoto Y; Nakajima N; Kinosita S
    Nippon Ganka Gakkai Zasshi; 1999 Feb; 103(2):144-8. PubMed ID: 10089754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic therapy for central retinal vein occlusion: results of a pilot study.
    Elman MJ
    Trans Am Ophthalmol Soc; 1996; 94():471-504. PubMed ID: 8981710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rationale of retinal endovascular fibrinolysis in the treatment of retinal vein occlusion: from experimental data to clinical application.
    Pournaras CJ; Petropoulos IK; Pournaras JA; Stangos AN; Gilodi N; Rungger-Brändle E
    Retina; 2012 Sep; 32(8):1566-73. PubMed ID: 22466460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment trials of plasminogen activator (rt-PA) in central vein thrombosis of the retina].
    Reim M; Bertram B; Wolf S
    Klin Wochenschr; 1988; 66 Suppl 12():143-9. PubMed ID: 3126343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal endovascular lysis.
    Weiss JN
    Ophthalmology; 2008 Jan; 115(1):216-7; author reply 218. PubMed ID: 18166422
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of vitrectomy assisted rt-PA injection for the management of branch retinal vein occlusion: case report.
    Christodoulakis EV; Tsilimbaris MK
    Semin Ophthalmol; 2007; 22(2):89-93. PubMed ID: 17564929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of central retinal vein occlusion by vitrectomy with lysis of vitreopapillary and epipapillary adhesions, subretinal peripapillary tissue plasminogen activator injection, and photocoagulation.
    Lam HD; Blumenkranz MS
    Am J Ophthalmol; 2002 Oct; 134(4):609-11. PubMed ID: 12383824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Front-loading rt PA thrombolytic therapy in central or venous branch occlusions of the retina].
    Steinkamp GW; Hattenbach LO; Scharrer I; Ohrloff C
    Ophthalmologe; 1994 Jun; 91(3):280-2. PubMed ID: 8086742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion.
    Lahey JM; Fong DS; Kearney J
    Ophthalmic Surg Lasers; 1999 Jun; 30(6):427-34. PubMed ID: 10392729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatments of central retinal vein occlusion.
    Parodi MB; Lanzetta P; Guarnaccia G; Friberg T
    Semin Ophthalmol; 2003 Sep; 18(3):142-6. PubMed ID: 15513475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal vein occlusion.
    Robinson MK; Halpern JI
    Am Fam Physician; 1992 Jun; 45(6):2661-6. PubMed ID: 1595515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical approach to retinal vein occlusion].
    Mester U
    Klin Monbl Augenheilkd; 2005 Apr; 222(4):299-308; quiz R19-R38. PubMed ID: 15844038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of surgical treatments for central retinal vein occlusion; RON vs. cannulation of tissue plasminogen activator into the retinal vein.
    Yamamoto T; Kamei M; Sakaguchi H; Oshima Y; Ikuno Y; Gomi F; Ohji M; Tano Y
    Retina; 2009 Sep; 29(8):1167-74. PubMed ID: 19734765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.